Lawyers Must File AFFF and PFAS Lawsuits by September 5, or Face New Requirements in MDL
Lawyers Must File AFFF and PFAS Lawsuits by September 5, or Face New Requirements in MDL – AboutLawsuits.com Skip Navigation […]
August 20, 2025
Investigational Rosnilimab Emerges as a Novel, Differentiated Treatment Option for Rheumatoid Arthritis
Rosnilimab, a selective depleter of pathogenic T cells, is a potential game changer for the treatment of moderate-to-severe rheumatoid arthritis
Direct to Patient Access: Empowering Motivated Patients in Today’s Changing Healthcare Landscape
Patients are taking a more active role in their journey to therapy, and direct-to-patient (DTP) models are transforming how pharmaceutical manufacturers